ESRT Earnings

ESRT reported its earnings on 2026-02-17, showcasing a revenue of 0.00 against an estimate of 0.00, resulting in a 0% surprise. The EPS was 0, surpassing the expected 0 by 0% . The stock experienced a 0% price change on the earnings day and a 0% change over the next five days, reflecting market reactions to the results.

Following ESRT's earnings announcement on 2026-02-17, the stock price moved by % on the day of the release. Over the subsequent five days, it saw a % change. Historically, ESRT's stock price tends to shift by an average of -0.01% in the 10 days leading up to earnings and +0.36% in the 10 days following, providing insight into potential market.

For 2025/Q2, analysts estimate ESRT’s annual revenue to reach 191.00M, while the EPS is projected at undefined. These estimates reflect recent revisions, with revenue estimates revised Revenue No Change by 0% and EPS estimates Go Down by -11.68% over the past three months, indicating analyst expectation in the company’s performance.

The correlation between ESRT's stock price and earnings forecast revisions shows that positive revisions in revenue or EPS often strengthen the stock’s fundamentals. Over the past three months, revenue estimates for FY2025 were No Change by 0%, while EPS estimates moved Go Down by -11.68% . This trend suggests that price dips could present buying opportunities for investors.

Based on historical trends, ESRT's stock price typically moves by -0.01% in the 10 days before its earnings and +0.36% in the 10 days after. For the upcoming 2025/Q2 earnings, analysts expect an EPS of undefined and revenue of 191.00M.

The earnings call summary indicates strong financial metrics, including increased NOI and FAD, high occupancy rates, and robust rent growth. The Q&A section reveals optimism from management regarding capital allocation, tenant demand, and market positioning. Despite some unclear responses, the overall sentiment is positive, with no significant negative trends or risks highlighted. The market cap suggests a moderate reaction, leading to a positive stock price prediction.